Garrigues acts for Grupo Ferrer on Alexza acquisition

Garrigues advised Spain’s Grupo Ferrer Internacional on the acquisition of US-based Alexza Pharmaceuticals for $0.90 per share in cash.


Grupo Ferrer was also advised on the transaction by Skadden, Arps, Slate, Meagher & Flom, while Alexza was advised by Cooley.

The deal was valued at €70m, according to Mergermarket.

An Alexza statement said: “The $0.90 per share cash consideration represents a 210 per cent premium to Alexza’s closing share price on February 26, 2016, the last trading day prior to announcement that Alexza and Ferrer had entered into a non-binding letter of intent with respect to Ferrer’s proposed acquisition of Alexza.”

It added: “Upon successful completion of the tender offer, Ferrer Pharma [a subsidiary of Grupo Ferrer] will acquire all remaining shares not tendered in the tender offer through a second-step merger at the same price and with the obligation to make the same contingent cash consideration payments as are made to stockholders tendering their shares in the tender offer.”  


Garrigues acts for Grupo Ferrer on Alexza acquisition

Ben Cook

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Lawyer
Registered office: C/ Manuel Silvela, 8 - Oficinas 1 Dcha 28010 Madrid España

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram